Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Ivantis Stock

Q: How to sell Ivantis stock?

If you hold private company shares of Ivantis - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Ivantis stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

ivantisinc.comHealthcare / Other HealthcareFounded: 1900Funding to Date: $132.88MM

lvantis is a healthcare company committed to expanding patient treatment and improving outcomes through new and innovative minimally invasive glaucoma surgical (MIGS) solutions, the fastest growing segment of the ophthalmology market.

Buy or sell Ivantis stockLearn more about Ivantis IPO

OverviewFinancingsValuation

Enterprise Value

Access Ivantis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Ivantis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Dave Van Meter

Chairman, President & Chief Executive Officer

Brandon Lorry

Senior Director

Kenneth Galt

Vice President, Research & Development

Brett Trauthen

Chief Scientific Officer

Board Members

Ben Gust

GBS Venture Partners

Albert Graf

New Enterprise Associates

Lincoln Chee Wang Jin

Randy Alexander

Brant Heise

MemorialCare Innovation Fund

Dave Van Meter

James Pade

Tara Butler MD

Ascension Ventures

Yoh-Chie Lu

Vertex Ventures HC

Ali Behbahani MD

New Enterprise Associates

Douglas Roeder

Delphi Ventures

John Nehra

New Enterprise Associates

Peter Kolchinsky Ph.D

RA Capital Management

Thong Yuen Poon Ph.D

EDBI

Ivantis stock FAQs

Can you buy Ivantis stock?

As Ivantis is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Ivantis, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Ivantis stock?

To invest in a private company like Ivantis through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Ivantis stock?

Yes, you may be able to sell your Ivantis stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Ivantis stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Ivantis stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Ivantis a public company?

No, Ivantis is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Ivantis’ stock price?

Ivantis is a privately held company and therefore does not have a public stock price. However, you may access Ivantis’ private market stock price with Forge Data.

What is Ivantis’ stock ticker symbol?

Ivantis does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

FinSMEs 01/10/2017

Ivantis Raises $25M in Series C Funding |FinSMEs

Ivantis Inc., an Irvine, CA-based developer of a device designed to lower eye pressure for glaucoma patients, closed a $25m Series C financing. The round was led by new investor RA Capital Management, with participation from new investor Mérieux Développement, as well as existing investors. The company intends to use the funds for US commercialization …

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Ivantis Stock

Register To Buy and Sell Shares

Enterprise Value

Access Ivantis’ valuation and stock price.

Team

Management Team

Board Members

Ivantis stock FAQs

Can you buy Ivantis stock?

How to buy Ivantis stock?

Can you sell Ivantis stock?

How to sell Ivantis stock?

Is Ivantis a public company?

What is Ivantis’ stock price?

What is Ivantis’ stock ticker symbol?

Can institutional investors buy and sell private market stocks?

Other companies like Ivantis in the Other Healthcare sector

Ivantis Raises $25M in Series C Funding |FinSMEs

Frequently Asked Questions

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES